CD CORR-OPIOID USE DISORDERS
What changed between versions
Added a requirement that medications be used only when clinically appropriate, replacing the previous blanket mandate.
Changed the minimum treatment target from 4,000 administrations to 3,000 individuals to better reflect patient counts rather than dosage volume.
Mandated that patients be connected to community treatment providers with scheduled appointments before release to ensure continuity of care.
Required the Department to contract with an independent entity to oversee the program.
Specified that the program must be funded using opioid settlement funds and cannot begin until those funds are secured.
Required the Department to publish eligibility criteria and use a fair, objective selection process if demand exceeds capacity.
Removed the requirement for a report to the General Assembly by January 1, 2028.